Logo image
A mechanism for improved talc pleurodesis via foam delivery
Journal article   Open access   Peer reviewed

A mechanism for improved talc pleurodesis via foam delivery

T. A. Lima, R. A. Coler, G. W. Laub, S. Sexton, L. Curtin, K. M. Laub and N. J. Alvarez
Drug delivery, v 28(1), pp 733-740
01 Jan 2021
PMID: 33827326
url
https://doi.org/10.1080/10717544.2021.1895910View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Drug delivery foam malignant pleural effusions pleurodesis rheology
Talcum powder is recognized as the leading drug for pleurodesis, a treatment of choice for malignant pleural effusions. Recently, it was shown that hydrogel foam delivery systems significantly enhanced the number of adhesions between the chest wall and the lung in a New Zealand rabbit model due to the sol-gel transition. However, many questions still remain regarding the cause of improved efficacy, such as: (1) Would only hydrogel foams improve the efficacy of talc pleurodesis? (2) Is it possible to achieve the same efficacy of hydrogels using non-hydrogel foams? 3) What are the physicochemical properties that can be correlated to the efficacy of talc pleurodesis? In this study, we use non-hydrogel foam formulations to determine the efficacy of pleurodesis. Foam stability and rheology of the formulations were correlated to adhesion formation. The results clearly suggest a correlation of pleurodesis efficacy to the viscosity and modulus of the foam delivery system.

Metrics

6 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image